Document Detail

Measurement of ischaemia-reperfusion in patients with intermittent claudication using NMR-based metabonomics.
MedLine Citation:
PMID:  18246538     Owner:  NLM     Status:  MEDLINE    
Intermittent claudication has proved to be a good in vivo model for ischaemia-reperfusion. For assessment of ischaemia-reperfusion damage, the known biochemical markers all have disadvantages with respect to sensitivity and interference with other physiological events. In this work, we studied the metabolic effects of ischaemia-reperfusion in patients with intermittent claudication, and the effects of vitamin C and E intervention, using both traditional biochemical measurements and 1H-NMR-based metabonomics on urine and plasma. The 1H-NMR spectra were subjected to multivariate modelling using principal components discriminant analysis, and the observed clusters were validated using joint deployment of univariate analysis of variance and Tukey-Kramer honestly significant difference (HSD) testing. The study involved 14 patients with intermittent claudication and three healthy volunteers, who were monitored during a walking test, before and after a vitamin C/E intervention, and after a washout period. The effect of exercise was only observable for a limited number of biochemical markers, whereas 1H NMR revealed an effect in line with anaerobic ATP production via glycolysis in exercising (ischaemic) muscle of the claudicants. Thus, the beneficial effect of vitamins C and E in claudicants was more pronounced when observed by metabonomics than by traditional biochemical markers. The main effect was more rapid recovery from exercise to resting state metabolism. Furthermore, after intervention, claudicants tended to have lower concentrations of lactate and glucose and several other citric acid cycle metabolites, whereas acetoacetate was increased. The observed metabolic changes in the plasma suggest that intake of vitamin C/E leads to increased muscle oxidative metabolism.
Stefan A Coolen; Clare A Daykin; John P M van Duynhoven; Ferdi A van Dorsten; Florian Wulfert; Jolanda Mathot; Marc R Scheltinga; Otto Stroosma; Huib Vader; Marc H Wijnen
Related Documents :
3809048 - Impotence and bicycling. a seldom-reported connection.
22105518 - The current standard measure of cardiorespiratory fitness introduces confounding by bod...
18246538 - Measurement of ischaemia-reperfusion in patients with intermittent claudication using n...
18357918 - Periodic whole body acceleration: a novel therapy for cardiovascular disease.
23365418 - Exercise during pregnancy and gestational diabetes-related adverse effects: a randomise...
23604068 - Sprint interval training in hypoxia stimulates glycolytic enzyme activity.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  NMR in biomedicine     Volume:  21     ISSN:  0952-3480     ISO Abbreviation:  NMR Biomed     Publication Date:  2008 Aug 
Date Detail:
Created Date:  2008-07-30     Completed Date:  2009-02-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8915233     Medline TA:  NMR Biomed     Country:  England    
Other Details:
Languages:  eng     Pagination:  686-95     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2008 John Wiley & Sons, Ltd.
Unilever Food and Health Research Institute, Vlaardingen, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antioxidants / metabolism
Ascorbic Acid / therapeutic use
Biological Markers
Blood Chemical Analysis
F2-Isoprostanes / blood
Intermittent Claudication / complications*,  drug therapy,  metabolism*
Magnetic Resonance Imaging*
Middle Aged
Reperfusion Injury / complications*,  metabolism*
Vitamin E / therapeutic use
Reg. No./Substance:
0/Antioxidants; 0/Biological Markers; 0/F2-Isoprostanes; 1406-18-4/Vitamin E; 50-81-7/Ascorbic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia.
Next Document:  Molecular electron paramagnetic resonance imaging of melanin in melanomas: a proof-of-concept.